Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01783093 · ClinicalTrials.gov registry record
Tricuspid Regurgitant Jet Velocity as an Independent Marker for Mortality in Sickle Cell Anemia
A clinical trial of Pulmonary Hypertension and Sickle Cell Anemia, sponsored by Namita Sood.
- Completed
- Registry status
- 209
- Enrollment target
- 1
- Study location
NCT01783093: Completed study of Pulmonary Hypertension and Sickle Cell Anemia, sponsored by Namita Sood.
NCT01783093 is a study of Pulmonary Hypertension and Sickle Cell Anemia that has completed, run by Namita Sood. The registered enrollment target is 209 participants, below the 611-participant average among 72 other Pulmonary Hypertension trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01783093, a study of Pulmonary Hypertension and Sickle Cell Anemia, has completed, sponsored by Namita Sood.
- COMPLETED
- Registry status
- 209 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate patients with pulmonary hypertension and sickle cell disease who have had multiple echocardiograms. Previous studies have shown that an elevated tricuspid jet (TR) regurgitant velocity on echo in this population is a predictor of mortality. This initial data only examined an isolated TR jet velocity. It was presumed that the mortality was related to pulmonary hypertension. It is the aim of this study to retrospectively evaluate patients who have had multiple echocardiograms and to determine if patients who had either a normalization of their TR jet velocity on a subsequent echo or had no evidence of pulmonary hypertension on right heart catheterization had a similar mortality rate to those with persistently elevated TR jet velocity.
Primary Outcome
Any subject's who meet criteria and have multiple echocardiograms may be included.
Conditions Studied
Interventions
- OTHER Data Collection
Study Locations (1)
Ohio
- The Ohio State University Medical Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 209 participants |
| Start Date | 2009-12 |
| Est. Completion | 2013-01 |
What the finished NCT01783093 record still lists
NCT01783093 is an observational study that tracks outcomes without assigning an intervention. The registered 209 participants enrollment target is mid-sized for trials with a published cap, below the 611-participant average among 72 other Pulmonary Hypertension trials with a reported enrollment target (66% lower).
The record links to 2 conditions, with Pulmonary Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Data Collection is the first listed.
NCT01783093 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT01783093 about?
NCT01783093 is a clinical study titled "Tricuspid Regurgitant Jet Velocity as an Independent Marker for Mortality in Sickle Cell Anemia". The purpose of this study is to evaluate patients with pulmonary hypertension and sickle cell disease who have had multiple echocardiograms. Previous studies have shown that an elevated tricuspid jet (TR) regurgitant velocity on echo in this population is a predictor of mortality. This initial data ...
What is the current status of trial NCT01783093?
This trial is currently completed. The enrollment target is 209 participants. The study started on 2009-12. Estimated completion is 2013-01.
What conditions does trial NCT01783093 study?
This clinical trial studies the following conditions: Pulmonary Hypertension, Sickle Cell Anemia.
What interventions are being tested in trial NCT01783093?
The interventions under investigation include: Data Collection (OTHER).
Who is sponsoring clinical trial NCT01783093?
This trial is sponsored by Namita Sood, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01783093 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01783093's enrollment target sits among peer trials
209 23rd of 72 higher than 50 of 72 other Pulmonary Hypertension trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pulmonary Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection
RECRUITING
-
Development of an Algorithm to Detect Pulmonary Hypertension Using an Electronic Stethoscope
RECRUITING
-
Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
RECRUITING · NA
-
Heart Institute Biobank & Registry for Adult Congenital Heart Disease and Related Disorders
RECRUITING
-
LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF
RECRUITING · Phase 3
-
Hemodynamic Assessment of underLying myocyTe Function in Right Heart Failure
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04742634 · 209 participants · Phase 1
Pre-emptive Therapy With DEC-C to Improve Outcomes in MDS Patients With Measurable Residual Disease Post Allogeneic Hematopoietic Cell Transplant
- NCT07214688 · 209 participants · Phase 2
Fludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo Transplant for Heme Malignancies
- NCT02665923 · 210 participants
Gastric Emptying in Neonates and Infants After Formula Feeding
- NCT03322891 · 210 participants · NA
Improving Health Literacy in African-American Prostate Cancer Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia